Здравоохранение Кыргызстана
Zdravoohraneniye Kyrgyzstana

ISSN 1694-8068 (Print)

ISSN 1694-805X (Online)

Влияние COVID-19 на реализацию мероприятий противотуберкулезной службой Кыргызской Республики

Влияние COVID-19 на реализацию мероприятий противотуберкулезной службой Кыргызской Республики
Полный текст Full text Толук текст  

Аннотация

В статье изложены данные по влиянию пандемии COVID-19 на реализацию противотуберкулезных ме- роприятий, в частности на выявление случаев туберкулеза по Кыргызской Республике. Для решения поставлен- ной цели были взяты отчетные данные отдела информатики и эпидемиологии Национального центра фтизиатрии за 2019-2021 годы. В анализ были включены данные по количеству зарегистрированных случаев туберкулеза (ТБ), показатели заболеваемости и смертности от ТБ в 2019-2021 гг. По данным НЦФ эпидемиологические по- казатели как заболеваемость и смертность от ТБ в 2020 году по сравнению с 2019 годом снизились значительно: показатель заболеваемости туберкулезом в 3,3 раза (с 78,9 до 53,5, ОШ=3,3, 95% ДИ 1,8-6,2, χ² и смертности не изменился, оставаясь на уровне 3,9). Значительное снижение уровня заболеваемости по туберкулезу (на 32,2%),связано со снижением выявления в связи с пандемией COVID-19. Противотуберкулезная служба несла сложности обеспечения кадрами во время пандемии, безусловно приведшее к ухудшению обслуживания пациентов с ТБ. Заболеваемость туберкулезом за 2021 год показывает об улучшении процессов диагностики туберкулеза и уве- личения количества зарегистрированных случаев (58,9 случаев на 100 тыс. населения). За последние 4 года самый высокий показатель заболеваемости туберкулезом в республике наблюдается в Чуйской области (124,2- 88,2), затем в регионах с большой численностью населения – г.Бишкеке (88,8-59,7), Жалал-Абадской (73,3-55,6) и Ошской области (75,0-55,9), а самый низкий показатель – в Иссык-Кульской области (48,9-37,5).

Об авторах

Абдрахманова Эльмира Джусупбековна, заведующая отделом информатики и эпидемиологии Национального Центра Фтизиатрии Министерства здравоохранения, Бишкек, Кыргызская Республика

Abdrakhmanova Elmira Dzhusupbekovna, Head of the Department of Informatics and Epidemiology of the National Center for Phthisiology, Ministry of Health, Bishkek, Kyrgyz Republic

Абдрахманова Эльмира Джусупбековна, информатика жана эпидемиология бѳлүмүнүн башчысы Кыргыз Республикасынын Саламаттык сактоо министрлигинин Улуттук фтизиатрия борбору,  Бишкек, Кыргыз Республикасы

Список литературы

1. World Health Organization.Global tuberculosis report; 2019. https://extranet.who.int/sree/Reports?op= Replet&name =/WHO_HQ_Reports/G2/PROD/EXT/TBCountryProfile&ISO2=ID&outtype=pdf [Mundus Health Organization. Global tuberculosis fama; 2019. https://extranet.who.int/sree/Reports op=Replet&name=/WHO_HQ_Reports/G2/PROD/EXT/TBCountryProfile&ISO2=ID&outtype=pdf]
2. World Health Organization. Global tuberculosis report; 2019. https://apps.who.int /iris/bitstream/handle/10665/329368/ 978924...-eng.pdf [accessed 8.10.20].[Mundus Health Organization. Global tuberculosis fama; 2019. https://apps.who.int /iris/bitstream/manubrio/10665/329368/978924...-eng.pdf [accessed 8.10.20].]
3. World Health Organization. Tuberculosis and COVID-19: Considerations for tuberculosis care; 2020. https://www.who.int/docs/default-source/documents/tuberculosis/…-tb-covid-19.pdf [accessed 8.10.20]. [Mundus Health Organization. Tuberculosis, et COVID-19: Considerationes pro tuberculosis cura; 2020. https://www.who.int/ docs/default-source/documentis/tuberculosis/...-tb-covid-19.pdf [accessed 8.10.20].]
4. Motta I, Centis R, D’Ambrosio L, García-García JM, Goletti D, Gualano G, et al. Tuberculosis COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts. Pulmonology. 2020; 26:233–40, http://dx.doi.org/ 10.1016/j.pulmoe.2020.05.002. [Motta ego, Centis R, D ' Ambrosio L, García-García JM, Goletti D, Gualano G, al. Tuberculosis COVID-19 et migrantes: Praevia analysis funera facta sunt in 69 aegros, ab duabus cohortibus. Pulmonology. 2020; 26:233-40, http://dx.doi.org/10.1016/j.pulmoe.2020.05.002.]
5. Tadolini M, Codecasa LR, García-García JM, Blanc FX, Borisov S, Alffenaar JW, et al. Active tuberculosis, sequelae and COVID-19 co-infection: First cohort of 49 cases. Eur Respir J. 2020; 56:2001398 http://dx.doi.org/10.1183/13993003.01398-2020. [Tadolini M, Codecasa LR, García-García JM, Blanc FX, Borisov S, Alffenaar JW, et al. Activa tuberculosis, sequelae et COVID-19 co-infectio: Prima cohors 49 casibus. Eur Respir J. 2020; 56:2001398. http://dx.doi.org/10.1183/13993003.01398-2020 .]
6. Buonsenso D. Iodice F,SorbaBiala J,GolettiD. COVID-19 effects on tuberculosis care in Sierra Leone. Pulmonology,
2020 http://dx.doi.org /10.1016/j.pulmoe.2020.05.013. [Buonsenso D. Iodice F, SorbaBiala J, GolettiD. COVID-19 effectus in tuberculosis cura in Sierra Leone. Pulmonology, 2020 http://dx.doi.org /10.1016/j.pulmoe.2020.05.013.]
7. Magro P, Formenti B, Marchese V, Gulletta M, Tomasoni LR, Caligaris S, et al. Impact of the SARS Coronavirus 2 epidemic ontuberculo sistreatment outcome, Northern Italy. Eur Respir J. 2020;56:2002665, http://dx.doi.org/10.1183/13993003.02665-2020 [Magro P, Formenti B, Marchese V, Gulletta M, Tomasoni LR, Caligaris S, al. Ictum SARS Coronavirus 2 pestilentia in tuberculo sis curatio exitus, Northern Italy. Eur Respir J. 2020; 56:2002665, http://dx.doi.org/10.1183/13993003.02665-2020 .]

1. World Health Organization.Global tuberculosis report; 2019. https://extranet.who.int/sree/Reports?op= Replet&name =/WHO_HQ_Reports/G2/PROD/EXT/TBCountryProfile&ISO2=ID&outtype=pdf [Mundus Health Organization. Global tuberculosis fama; 2019. https://extranet.who.int/sree/Reports op=Replet&name=/WHO_HQ_Reports/G2/PROD/EXT/TBCountryProfile&ISO2=ID&outtype=pdf]
2. World Health Organization. Global tuberculosis report; 2019. https://apps.who.int /iris/bitstream/handle/10665/329368/ 978924...-eng.pdf [accessed 8.10.20].[Mundus Health Organization. Global tuberculosis fama; 2019. https://apps.who.int /iris/bitstream/manubrio/10665/329368/978924...-eng.pdf [accessed 8.10.20].]
3. World Health Organization. Tuberculosis and COVID-19: Considerations for tuberculosis care; 2020. https://www.who.int/docs/default-source/documents/tuberculosis/…-tb-covid-19.pdf [accessed 8.10.20]. [Mundus Health Organization. Tuberculosis, et COVID-19: Considerationes pro tuberculosis cura; 2020. https://www.who.int/ docs/default-source/documentis/tuberculosis/...-tb-covid-19.pdf [accessed 8.10.20].]
4. Motta I, Centis R, D’Ambrosio L, García-García JM, Goletti D, Gualano G, et al. Tuberculosis COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts. Pulmonology. 2020; 26:233–40, http://dx.doi.org/ 10.1016/j.pulmoe.2020.05.002. [Motta ego, Centis R, D ' Ambrosio L, García-García JM, Goletti D, Gualano G, al. Tuberculosis COVID-19 et migrantes: Praevia analysis funera facta sunt in 69 aegros, ab duabus cohortibus. Pulmonology. 2020; 26:233-40, http://dx.doi.org/10.1016/j.pulmoe.2020.05.002.]
5. Tadolini M, Codecasa LR, García-García JM, Blanc FX, Borisov S, Alffenaar JW, et al. Active tuberculosis, sequelae and COVID-19 co-infection: First cohort of 49 cases. Eur Respir J. 2020; 56:2001398 http://dx.doi.org/10.1183/13993003.01398-2020. [Tadolini M, Codecasa LR, García-García JM, Blanc FX, Borisov S, Alffenaar JW, et al. Activa tuberculosis, sequelae et COVID-19 co-infectio: Prima cohors 49 casibus. Eur Respir J. 2020; 56:2001398. http://dx.doi.org/10.1183/13993003.01398-2020 .]
6. Buonsenso D. Iodice F,SorbaBiala J,GolettiD. COVID-19 effects on tuberculosis care in Sierra Leone. Pulmonology,
2020 http://dx.doi.org /10.1016/j.pulmoe.2020.05.013. [Buonsenso D. Iodice F, SorbaBiala J, GolettiD. COVID-19 effectus in tuberculosis cura in Sierra Leone. Pulmonology, 2020 http://dx.doi.org /10.1016/j.pulmoe.2020.05.013.]
7. Magro P, Formenti B, Marchese V, Gulletta M, Tomasoni LR, Caligaris S, et al. Impact of the SARS Coronavirus 2 epidemic ontuberculo sistreatment outcome, Northern Italy. Eur Respir J. 2020;56:2002665, http://dx.doi.org/10.1183/13993003.02665-2020 [Magro P, Formenti B, Marchese V, Gulletta M, Tomasoni LR, Caligaris S, al. Ictum SARS Coronavirus 2 pestilentia in tuberculo sis curatio exitus, Northern Italy. Eur Respir J. 2020; 56:2002665, http://dx.doi.org/10.1183/13993003.02665-2020 .]

1. World Health Organization.Global tuberculosis report; 2019. https://extranet.who.int/sree/Reports?op= Replet&name =/WHO_HQ_Reports/G2/PROD/EXT/TBCountryProfile&ISO2=ID&outtype=pdf [Mundus Health Organization. Global tuberculosis fama; 2019. https://extranet.who.int/sree/Reports op=Replet&name=/WHO_HQ_Reports/G2/PROD/EXT/TBCountryProfile&ISO2=ID&outtype=pdf]
2. World Health Organization. Global tuberculosis report; 2019. https://apps.who.int /iris/bitstream/handle/10665/329368/ 978924...-eng.pdf [accessed 8.10.20].[Mundus Health Organization. Global tuberculosis fama; 2019. https://apps.who.int /iris/bitstream/manubrio/10665/329368/978924...-eng.pdf [accessed 8.10.20].]
3. World Health Organization. Tuberculosis and COVID-19: Considerations for tuberculosis care; 2020. https://www.who.int/docs/default-source/documents/tuberculosis/…-tb-covid-19.pdf [accessed 8.10.20]. [Mundus Health Organization. Tuberculosis, et COVID-19: Considerationes pro tuberculosis cura; 2020. https://www.who.int/ docs/default-source/documentis/tuberculosis/...-tb-covid-19.pdf [accessed 8.10.20].]
4. Motta I, Centis R, D’Ambrosio L, García-García JM, Goletti D, Gualano G, et al. Tuberculosis COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts. Pulmonology. 2020; 26:233–40, http://dx.doi.org/ 10.1016/j.pulmoe.2020.05.002. [Motta ego, Centis R, D ' Ambrosio L, García-García JM, Goletti D, Gualano G, al. Tuberculosis COVID-19 et migrantes: Praevia analysis funera facta sunt in 69 aegros, ab duabus cohortibus. Pulmonology. 2020; 26:233-40, http://dx.doi.org/10.1016/j.pulmoe.2020.05.002.]
5. Tadolini M, Codecasa LR, García-García JM, Blanc FX, Borisov S, Alffenaar JW, et al. Active tuberculosis, sequelae and COVID-19 co-infection: First cohort of 49 cases. Eur Respir J. 2020; 56:2001398 http://dx.doi.org/10.1183/13993003.01398-2020. [Tadolini M, Codecasa LR, García-García JM, Blanc FX, Borisov S, Alffenaar JW, et al. Activa tuberculosis, sequelae et COVID-19 co-infectio: Prima cohors 49 casibus. Eur Respir J. 2020; 56:2001398. http://dx.doi.org/10.1183/13993003.01398-2020 .]
6. Buonsenso D. Iodice F,SorbaBiala J,GolettiD. COVID-19 effects on tuberculosis care in Sierra Leone. Pulmonology,
2020 http://dx.doi.org /10.1016/j.pulmoe.2020.05.013. [Buonsenso D. Iodice F, SorbaBiala J, GolettiD. COVID-19 effectus in tuberculosis cura in Sierra Leone. Pulmonology, 2020 http://dx.doi.org /10.1016/j.pulmoe.2020.05.013.]
7. Magro P, Formenti B, Marchese V, Gulletta M, Tomasoni LR, Caligaris S, et al. Impact of the SARS Coronavirus 2 epidemic ontuberculo sistreatment outcome, Northern Italy. Eur Respir J. 2020;56:2002665, http://dx.doi.org/10.1183/13993003.02665-2020 [Magro P, Formenti B, Marchese V, Gulletta M, Tomasoni LR, Caligaris S, al. Ictum SARS Coronavirus 2 pestilentia in tuberculo sis curatio exitus, Northern Italy. Eur Respir J. 2020; 56:2002665, http://dx.doi.org/10.1183/13993003.02665-2020 .]

Для цитирования

Абдрахманова Э.Д. Влияние COVID-19 на реализацию мероприятий противотуберкулезной службой Кыргызской Республики. Здравоохранение Кыргызстана 2022, № 2, с. 108-113. https://dx.doi.org/10.51350/zdravkg20226215108

For citation

Abdrakhmanova E.D. Impact of COVID-19 on the implementation of activities by the anti-tuberculosis service of the Kyrgyz Republic. Health care of Kyrgyzstan 2022,No.2, pp. 108-113. https://dx.doi.org/10.51350/zdravkg20226215108

Цитата үчүн

Абдрахманова Э.Д. COVID-19дун Кыргыз Республикасынын кургак учукка каршы кызматынын иш-чараларын ишке ашыруусуна тийгизген таасири. Кыргызстандын саламаттык сактоо 2022, no 2, б. 108 113. https://dx.doi.org/10.51350/zdravkg20226215108

Авторы Абдрахманова Э.Д.
Ссылка doi.org https://doi.org/10.51350/zdravkg20226215108
Страницы 108-113
Ключевые слова COVID-19, туберкулез, Заболеваемость, смертность от туберкулеза, выявляемость туберкулеза
Русский
Об авторах

Абдрахманова Эльмира Джусупбековна, заведующая отделом информатики и эпидемиологии Национального Центра Фтизиатрии Министерства здравоохранения, Бишкек, Кыргызская Республика

Полный текст

PDF (RUS)

Список литературы

1. World Health Organization.Global tuberculosis report; 2019. https://extranet.who.int/sree/Reports?op= Replet&name =/WHO_HQ_Reports/G2/PROD/EXT/TBCountryProfile&ISO2=ID&outtype=pdf [Mundus Health Organization. Global tuberculosis fama; 2019. https://extranet.who.int/sree/Reports op=Replet&name=/WHO_HQ_Reports/G2/PROD/EXT/TBCountryProfile&ISO2=ID&outtype=pdf]
2. World Health Organization. Global tuberculosis report; 2019. https://apps.who.int /iris/bitstream/handle/10665/329368/ 978924...-eng.pdf [accessed 8.10.20].[Mundus Health Organization. Global tuberculosis fama; 2019. https://apps.who.int /iris/bitstream/manubrio/10665/329368/978924...-eng.pdf [accessed 8.10.20].]
3. World Health Organization. Tuberculosis and COVID-19: Considerations for tuberculosis care; 2020. https://www.who.int/docs/default-source/documents/tuberculosis/…-tb-covid-19.pdf [accessed 8.10.20]. [Mundus Health Organization. Tuberculosis, et COVID-19: Considerationes pro tuberculosis cura; 2020. https://www.who.int/ docs/default-source/documentis/tuberculosis/...-tb-covid-19.pdf [accessed 8.10.20].]
4. Motta I, Centis R, D’Ambrosio L, García-García JM, Goletti D, Gualano G, et al. Tuberculosis COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts. Pulmonology. 2020; 26:233–40, http://dx.doi.org/ 10.1016/j.pulmoe.2020.05.002. [Motta ego, Centis R, D ' Ambrosio L, García-García JM, Goletti D, Gualano G, al. Tuberculosis COVID-19 et migrantes: Praevia analysis funera facta sunt in 69 aegros, ab duabus cohortibus. Pulmonology. 2020; 26:233-40, http://dx.doi.org/10.1016/j.pulmoe.2020.05.002.]
5. Tadolini M, Codecasa LR, García-García JM, Blanc FX, Borisov S, Alffenaar JW, et al. Active tuberculosis, sequelae and COVID-19 co-infection: First cohort of 49 cases. Eur Respir J. 2020; 56:2001398 http://dx.doi.org/10.1183/13993003.01398-2020. [Tadolini M, Codecasa LR, García-García JM, Blanc FX, Borisov S, Alffenaar JW, et al. Activa tuberculosis, sequelae et COVID-19 co-infectio: Prima cohors 49 casibus. Eur Respir J. 2020; 56:2001398. http://dx.doi.org/10.1183/13993003.01398-2020 .]
6. Buonsenso D. Iodice F,SorbaBiala J,GolettiD. COVID-19 effects on tuberculosis care in Sierra Leone. Pulmonology,
2020 http://dx.doi.org /10.1016/j.pulmoe.2020.05.013. [Buonsenso D. Iodice F, SorbaBiala J, GolettiD. COVID-19 effectus in tuberculosis cura in Sierra Leone. Pulmonology, 2020 http://dx.doi.org /10.1016/j.pulmoe.2020.05.013.]
7. Magro P, Formenti B, Marchese V, Gulletta M, Tomasoni LR, Caligaris S, et al. Impact of the SARS Coronavirus 2 epidemic ontuberculo sistreatment outcome, Northern Italy. Eur Respir J. 2020;56:2002665, http://dx.doi.org/10.1183/13993003.02665-2020 [Magro P, Formenti B, Marchese V, Gulletta M, Tomasoni LR, Caligaris S, al. Ictum SARS Coronavirus 2 pestilentia in tuberculo sis curatio exitus, Northern Italy. Eur Respir J. 2020; 56:2002665, http://dx.doi.org/10.1183/13993003.02665-2020 .]

Для цитирования

Абдрахманова Э.Д. Влияние COVID-19 на реализацию мероприятий противотуберкулезной службой Кыргызской Республики. Здравоохранение Кыргызстана 2022, № 2, с. 108-113. https://dx.doi.org/10.51350/zdravkg20226215108

Английский
About authors

Abdrakhmanova Elmira Dzhusupbekovna, Head of the Department of Informatics and Epidemiology of the National Center for Phthisiology, Ministry of Health, Bishkek, Kyrgyz Republic

Full text

PDF (RUS)

References

1. World Health Organization.Global tuberculosis report; 2019. https://extranet.who.int/sree/Reports?op= Replet&name =/WHO_HQ_Reports/G2/PROD/EXT/TBCountryProfile&ISO2=ID&outtype=pdf [Mundus Health Organization. Global tuberculosis fama; 2019. https://extranet.who.int/sree/Reports op=Replet&name=/WHO_HQ_Reports/G2/PROD/EXT/TBCountryProfile&ISO2=ID&outtype=pdf]
2. World Health Organization. Global tuberculosis report; 2019. https://apps.who.int /iris/bitstream/handle/10665/329368/ 978924...-eng.pdf [accessed 8.10.20].[Mundus Health Organization. Global tuberculosis fama; 2019. https://apps.who.int /iris/bitstream/manubrio/10665/329368/978924...-eng.pdf [accessed 8.10.20].]
3. World Health Organization. Tuberculosis and COVID-19: Considerations for tuberculosis care; 2020. https://www.who.int/docs/default-source/documents/tuberculosis/…-tb-covid-19.pdf [accessed 8.10.20]. [Mundus Health Organization. Tuberculosis, et COVID-19: Considerationes pro tuberculosis cura; 2020. https://www.who.int/ docs/default-source/documentis/tuberculosis/...-tb-covid-19.pdf [accessed 8.10.20].]
4. Motta I, Centis R, D’Ambrosio L, García-García JM, Goletti D, Gualano G, et al. Tuberculosis COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts. Pulmonology. 2020; 26:233–40, http://dx.doi.org/ 10.1016/j.pulmoe.2020.05.002. [Motta ego, Centis R, D ' Ambrosio L, García-García JM, Goletti D, Gualano G, al. Tuberculosis COVID-19 et migrantes: Praevia analysis funera facta sunt in 69 aegros, ab duabus cohortibus. Pulmonology. 2020; 26:233-40, http://dx.doi.org/10.1016/j.pulmoe.2020.05.002.]
5. Tadolini M, Codecasa LR, García-García JM, Blanc FX, Borisov S, Alffenaar JW, et al. Active tuberculosis, sequelae and COVID-19 co-infection: First cohort of 49 cases. Eur Respir J. 2020; 56:2001398 http://dx.doi.org/10.1183/13993003.01398-2020. [Tadolini M, Codecasa LR, García-García JM, Blanc FX, Borisov S, Alffenaar JW, et al. Activa tuberculosis, sequelae et COVID-19 co-infectio: Prima cohors 49 casibus. Eur Respir J. 2020; 56:2001398. http://dx.doi.org/10.1183/13993003.01398-2020 .]
6. Buonsenso D. Iodice F,SorbaBiala J,GolettiD. COVID-19 effects on tuberculosis care in Sierra Leone. Pulmonology,
2020 http://dx.doi.org /10.1016/j.pulmoe.2020.05.013. [Buonsenso D. Iodice F, SorbaBiala J, GolettiD. COVID-19 effectus in tuberculosis cura in Sierra Leone. Pulmonology, 2020 http://dx.doi.org /10.1016/j.pulmoe.2020.05.013.]
7. Magro P, Formenti B, Marchese V, Gulletta M, Tomasoni LR, Caligaris S, et al. Impact of the SARS Coronavirus 2 epidemic ontuberculo sistreatment outcome, Northern Italy. Eur Respir J. 2020;56:2002665, http://dx.doi.org/10.1183/13993003.02665-2020 [Magro P, Formenti B, Marchese V, Gulletta M, Tomasoni LR, Caligaris S, al. Ictum SARS Coronavirus 2 pestilentia in tuberculo sis curatio exitus, Northern Italy. Eur Respir J. 2020; 56:2002665, http://dx.doi.org/10.1183/13993003.02665-2020 .]

For citation

Abdrakhmanova E.D. Impact of COVID-19 on the implementation of activities by the anti-tuberculosis service of the Kyrgyz Republic. Health care of Kyrgyzstan 2022,No.2, pp. 108-113. https://dx.doi.org/10.51350/zdravkg20226215108

Кыргызский
Авторлор жөнүндө

Абдрахманова Эльмира Джусупбековна, информатика жана эпидемиология бѳлүмүнүн башчысы Кыргыз Республикасынын Саламаттык сактоо министрлигинин Улуттук фтизиатрия борбору,  Бишкек, Кыргыз Республикасы

Толук текст

PDF (RUS)

Шилтемелер

1. World Health Organization.Global tuberculosis report; 2019. https://extranet.who.int/sree/Reports?op= Replet&name =/WHO_HQ_Reports/G2/PROD/EXT/TBCountryProfile&ISO2=ID&outtype=pdf [Mundus Health Organization. Global tuberculosis fama; 2019. https://extranet.who.int/sree/Reports op=Replet&name=/WHO_HQ_Reports/G2/PROD/EXT/TBCountryProfile&ISO2=ID&outtype=pdf]
2. World Health Organization. Global tuberculosis report; 2019. https://apps.who.int /iris/bitstream/handle/10665/329368/ 978924...-eng.pdf [accessed 8.10.20].[Mundus Health Organization. Global tuberculosis fama; 2019. https://apps.who.int /iris/bitstream/manubrio/10665/329368/978924...-eng.pdf [accessed 8.10.20].]
3. World Health Organization. Tuberculosis and COVID-19: Considerations for tuberculosis care; 2020. https://www.who.int/docs/default-source/documents/tuberculosis/…-tb-covid-19.pdf [accessed 8.10.20]. [Mundus Health Organization. Tuberculosis, et COVID-19: Considerationes pro tuberculosis cura; 2020. https://www.who.int/ docs/default-source/documentis/tuberculosis/...-tb-covid-19.pdf [accessed 8.10.20].]
4. Motta I, Centis R, D’Ambrosio L, García-García JM, Goletti D, Gualano G, et al. Tuberculosis COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts. Pulmonology. 2020; 26:233–40, http://dx.doi.org/ 10.1016/j.pulmoe.2020.05.002. [Motta ego, Centis R, D ' Ambrosio L, García-García JM, Goletti D, Gualano G, al. Tuberculosis COVID-19 et migrantes: Praevia analysis funera facta sunt in 69 aegros, ab duabus cohortibus. Pulmonology. 2020; 26:233-40, http://dx.doi.org/10.1016/j.pulmoe.2020.05.002.]
5. Tadolini M, Codecasa LR, García-García JM, Blanc FX, Borisov S, Alffenaar JW, et al. Active tuberculosis, sequelae and COVID-19 co-infection: First cohort of 49 cases. Eur Respir J. 2020; 56:2001398 http://dx.doi.org/10.1183/13993003.01398-2020. [Tadolini M, Codecasa LR, García-García JM, Blanc FX, Borisov S, Alffenaar JW, et al. Activa tuberculosis, sequelae et COVID-19 co-infectio: Prima cohors 49 casibus. Eur Respir J. 2020; 56:2001398. http://dx.doi.org/10.1183/13993003.01398-2020 .]
6. Buonsenso D. Iodice F,SorbaBiala J,GolettiD. COVID-19 effects on tuberculosis care in Sierra Leone. Pulmonology,
2020 http://dx.doi.org /10.1016/j.pulmoe.2020.05.013. [Buonsenso D. Iodice F, SorbaBiala J, GolettiD. COVID-19 effectus in tuberculosis cura in Sierra Leone. Pulmonology, 2020 http://dx.doi.org /10.1016/j.pulmoe.2020.05.013.]
7. Magro P, Formenti B, Marchese V, Gulletta M, Tomasoni LR, Caligaris S, et al. Impact of the SARS Coronavirus 2 epidemic ontuberculo sistreatment outcome, Northern Italy. Eur Respir J. 2020;56:2002665, http://dx.doi.org/10.1183/13993003.02665-2020 [Magro P, Formenti B, Marchese V, Gulletta M, Tomasoni LR, Caligaris S, al. Ictum SARS Coronavirus 2 pestilentia in tuberculo sis curatio exitus, Northern Italy. Eur Respir J. 2020; 56:2002665, http://dx.doi.org/10.1183/13993003.02665-2020 .]

Цитата үчүн

Абдрахманова Э.Д. COVID-19дун Кыргыз Республикасынын кургак учукка каршы кызматынын иш-чараларын ишке ашыруусуна тийгизген таасири. Кыргызстандын саламаттык сактоо 2022, no 2, б. 108 113. https://dx.doi.org/10.51350/zdravkg20226215108

Просмотров: 4241
Copyright MAXXmarketing GmbH
JoomShopping Download & Support